Add to Quick Collection All 4 Results
| Title | Author/Creator | Date | Full Text | Reviewed | |
|---|---|---|---|---|---|
| Challenges and progress in adverse event ascertainment and reporting in clinical trials | Lassere, M. N. D.; Johnson, Kent R.; Woodworth, T. G.; Furst, D. E.; Fries, J. F.... More | 2005 | — | ||
| Generic patient self-report and investigator report instruments of therapeutic safety and tolerability | Lassere, M. N. D.; Johnson, Kent R.; Van Santen, S.; Carlton, K.; Rappo, J.... More | 2005 | — | ||
| Minimal disease activity for rheumatoid arthritis: a preliminary definition | Wells, G. A.; Boers, M.; Shea, B.; Brooks, P. M.; Simon, L. S.... More | 2005 | — | ||
| Standardized assessment of adverse events in rheumatology clinical trials: Summary of the OMERACT 7 Drug Safety Module update | Lassere, M. N. D.; Johnson, Kent R.; Boers, M.; Carlton, K.; Day, R. O.... More | 2005 | — |